{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:17:16Z","timestamp":1792117036611,"version":"4.4.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.berh.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T19:39:32Z","timestamp":1540496372000},"page":"846-862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Uveitis in the Spondyloarthopathies"],"prefix":"10.1016","volume":"31","author":[{"given":"Srilakshmi M.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.berh.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.berh.2018.08.002_bib3","first-page":"322","article-title":"Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis","volume":"29","author":"Stoll","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2018.02.019","article-title":"Autoimmunity, autoinflammation, and infection in uveitis","volume":"189","author":"Forrester","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bjo.86.4.412","article-title":"Systemic inflammation and innate immune response in patients with previous anterior uveitis","volume":"86","author":"Huhtinen","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2174\/1566524015666150731100012","article-title":"Cytokine expression profile in aqueous humor and sera of patients with acute anterior uveitis","volume":"15","author":"Chen","year":"2015","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.berh.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1167\/iovs.05-0836","article-title":"Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis","volume":"47","author":"Takase","year":"2006","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2018.08.002_bib8","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1167\/iovs.09-4460","article-title":"Suppression of bystander T helper 1 cells by iris pigment epithelium-inducing regulatory T cells via negative costimulatory signals","volume":"51","author":"Sugita","year":"2010","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2018.08.002_bib9","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1167\/iovs.05-1547","article-title":"Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens","volume":"47","author":"Sugita","year":"2006","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"Pt 3A","key":"10.1016\/j.berh.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2000.84","article-title":"Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis","volume":"14","author":"Benitez-Del-Castillo","year":"2000","journal-title":"Eye"},{"key":"10.1016\/j.berh.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00951804","article-title":"Blood-aqueous barrier permeability determination in HLA B27-positive acute anterior uveitis patients","volume":"18","author":"Benitez-Del-Castillo","year":"1994","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib12","first-page":"35","article-title":"Complement and polymorphonuclear leukocytes do not determine the vascular permeability induced by intraocular LPS","volume":"118","author":"Howes","year":"1985","journal-title":"Am J Pathol"},{"key":"10.1016\/j.berh.2018.08.002_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.preteyeres.2012.10.004","article-title":"A contemporary concept of the blood-aqueous barrier","volume":"32","author":"Freddo","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.berh.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/286611a0","article-title":"Endotoxin-induced uveitis in rats as a model for human disease","volume":"286","author":"Rosenbaum","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.berh.2018.08.002_bib15","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1167\/iovs.16-19276","article-title":"Quantitative assessment of anterior segment inflammation in a rat model of uveitis using spectral-domain optical coherence tomography","volume":"57","author":"Pepple","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"8438","DOI":"10.1167\/iovs.15-17523","article-title":"Primed mycobacterial uveitis (PMU): histologic and cytokine characterization of a model of uveitis in rats","volume":"56","author":"Pepple","year":"2015","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2018.08.002_bib17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.33404","article-title":"Interferon-\u03b3 regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis","volume":"64","author":"Kezic","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-1759(00)00165-4","article-title":"Digital video-imaging of leukocyte migration in the iris: intravital microscopy in a physiological model during the onset of endotoxin-induced uveitis","volume":"240","author":"Becker","year":"2000","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.berh.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/acr.21616","article-title":"Prevalence and factors associated with uveitis in spondylarthritis patients in France: results from an observational survey","volume":"64","author":"Canou\u00ef-Poitrine","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2018.08.002_bib20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/ard.2007.075754","article-title":"Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review","volume":"67","author":"Zeboulon","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1590\/S0482-50042010000500009","article-title":"Spondyloarthritis: analysis of a Brazilian series compared with a large Ibero-American registry (RESPONDIA group)","volume":"50","author":"Gallinaro","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-006-0203-7","article-title":"Characterization and outcome of uveitis in 350 patients with spondyloarthropathies","volume":"26","author":"Sampaio-Barros","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2018.08.002_bib23","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/36.7.766","article-title":"The outcome of ankylosing spondylitis: a study of 100 patients","volume":"36","author":"Gran","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/bjo.2002.013334","article-title":"The risk of complications of uveitis in a district hospital cohort","volume":"88","author":"Maini","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.59.1.67","article-title":"Characterisation of uveitis in patients with psoriatic arthritis","volume":"59","author":"Paiva","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10067-014-2652-9","article-title":"Extra-articular manifestations in psoriatic arthritis patients","volume":"34","author":"Peluso","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib27","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ard.35.4.354","article-title":"Eye inflammation in psoriatic arthritis","volume":"35","author":"Lambert","year":"1976","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","article-title":"The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients","volume":"55","author":"Greenstein","year":"1976","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.berh.2018.08.002_bib29","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.berh.2018.08.002_bib30","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00384-007-0275-1","article-title":"The prevalence of ocular involvement in patients with inflammatory bowel disease","volume":"22","author":"Yilmaz","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib31","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamadermatol.2015.1986","article-title":"Association of psoriatic disease with uveitis: a Danish nationwide cohort study","volume":"151","author":"Egeberg","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.berh.2018.08.002_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.survophthal.2005.04.003","article-title":"Acute anterior uveitis and HLA-B27","volume":"50","author":"Chang","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1076\/ocii.10.4.263.15592","article-title":"Uveitis: a global perspective","volume":"10","author":"Chang","year":"2002","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2018.08.002_bib34","first-page":"35","article-title":"Causes of uveitis in the general practice of ophthalmology. UCLA community-based uveitis study group","volume":"121","author":"McCannel","year":"1996","journal-title":"AJOPHT"},{"key":"10.1016\/j.berh.2018.08.002_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1755-3768.1994.tb02805.x","article-title":"Uveitis survey at the university eye clinic in turku","volume":"72","author":"P\u00e4iv\u00f6nsalo-Hietanen","year":"1994","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib37","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1136\/annrheumdis-2014-205358","article-title":"Novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool)","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/bjo.59.5.270","article-title":"HL-A 27 and acute anterior uveitis","volume":"59","author":"Mapstone","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"OPHTHA"},{"key":"10.1016\/j.berh.2018.08.002_bib40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.4.5.4","article-title":"Automated analysis of vitreous inflammation using spectral-domain optical coherence tomography","volume":"4","author":"Keane","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.berh.2018.08.002_bib41","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3899\/jrheum.131289","article-title":"Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis","volume":"41","author":"van Denderen","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/03009740802385423","article-title":"Prevalence of spondyloarthritis in 504 Chinese patients with HLA-B27-associated acute anterior uveitis","volume":"38","author":"Chung","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib43","first-page":"317","article-title":"Anterior uveitis and hypopyon","volume":"112","author":"D'Alessandro","year":"1991","journal-title":"AJOPHT"},{"key":"10.1016\/j.berh.2018.08.002_bib44","first-page":"484","article-title":"An analysis of 372 patients with anterior uveitis in a large Ibero-American cohort of spondyloarthritis: the RESPONDIA Group","volume":"31","author":"Sampaio-Barros","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archopht.1997.01100150063010","article-title":"Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy","volume":"115","author":"Lyons","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/BOR.0000000000000185","article-title":"Juvenile spondyloarthritis","volume":"27","author":"Gmuca","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrrheum.2010.103","article-title":"Classification of juvenile spondyloarthritis: enthesitis-related arthritis and beyond","volume":"6","author":"Colbert","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/bjo.2004.050609","article-title":"Uveitis in children and adolescents","volume":"89","author":"BenEzra","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3748\/wjg.v20.i1.45","article-title":"Current issues in pediatric inflammatory bowel disease-associated arthropathies","volume":"20","author":"Cardile","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.berh.2018.08.002_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MPG.0000000000001455","article-title":"Extraintestinal manifestations of pediatric inflammatory bowel disease: prevalence, presentation, and anti-TNF treatment","volume":"65","author":"Greuter","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.berh.2018.08.002_bib51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0889-857X(21)01001-2","article-title":"Therapeutic approaches for ophthalmic problems in juvenile rheumatoid arthritis","volume":"15","author":"O'Brien","year":"1989","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.berh.2018.08.002_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2010.04.031","article-title":"Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis","volume":"150","author":"Loh","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajo.2016.02.024","article-title":"Potential predictors of poor visual outcome in human leukocyte antigen-B27\u2013associated uveitis","volume":"165","author":"Verhagen","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.ijg.0000146391.77618.d0","article-title":"Incidence of glaucoma in patients with uveitis","volume":"13","author":"Neri","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1016\/j.berh.2018.08.002_bib55","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0039-6257(97)00006-4","article-title":"Glaucoma associated with uveitis","volume":"41","author":"Moorthy","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9394(14)70533-1","article-title":"Clinical features and associated systemic diseases of HLA-B27 uveitis","volume":"121","author":"Tay-Kearney","year":"1996","journal-title":"Am J Ophth"},{"key":"10.1016\/j.berh.2018.08.002_bib57","doi-asserted-by":"crossref","first-page":"e0146956","DOI":"10.1371\/journal.pone.0146956","article-title":"Vision-Related Quality of Life in Patients with Inactive HLA-B27\u2013Associated-Spectrum Anterior Uveitis","volume":"11","author":"Hoeksema","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.berh.2018.08.002_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","article-title":"Genetics of spondyloarthritis--beyond the MHC","volume":"8","author":"Reveille","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib59","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","article-title":"Ankylosing spondylitis and HL-A 27","volume":"1","author":"Brewerton","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2018.08.002_bib60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/ard.33.4.406","article-title":"Proceedings: histocompatibility antigen (HL-A 27) and its relation to disease","volume":"33","author":"Brewerton","year":"1974","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib61","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.08.002_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/gene.2015.49","article-title":"The genetic associations of acute anterior uveitis and their overlap with the genetics of ankylosing spondylitis","volume":"17","author":"Robinson","year":"2016","journal-title":"Gene Immun"},{"key":"10.1016\/j.berh.2018.08.002_bib63","first-page":"2568","article-title":"The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27","volume":"32","author":"Linssen","year":"1991","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2018.08.002_bib64","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/BOR.0b013e3283364483","article-title":"Genetics of ankylosing spondylitis","volume":"22","author":"Brown","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib65","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"International Genetics of Ankylosing Spondylitis Consortium (IGAS)","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.berh.2018.08.002_bib66","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2011.150102","article-title":"Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis","volume":"70","author":"Bowes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib67","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.berh.2018.08.002_bib68","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","article-title":"Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility","volume":"43","author":"Evans","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.berh.2018.08.002_bib69","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9394(98)00100-7","article-title":"Association between MICA gene A4 allele and acute anterior uveitis in white patients with and without HLA-B27","volume":"126","author":"Goto","year":"1998","journal-title":"Am J Ophth"},{"key":"10.1016\/j.berh.2018.08.002_bib70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/art.38873","article-title":"Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis","volume":"67","author":"Robinson","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.08.002_bib71","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1167\/iovs.14-15460","article-title":"FoxO1 gene confers genetic predisposition to acute anterior uveitis with ankylosing spondylitis","volume":"55","author":"Yu","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2018.08.002_bib72","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.56.8.488","article-title":"The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis","volume":"56","author":"Maksymowych","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib73","first-page":"42","article-title":"Polymorphism in the LMP2 gene influences the relative risk for acute anterior uveitis in unselected patients with ankylosing spondylitis","volume":"18","author":"Maksymowych","year":"1995","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.berh.2018.08.002_bib74","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/1566524018666180207154938","article-title":"Association of IL33 and IL1RAP polymorphisms with acute anterior uveitis","volume":"17","author":"Huang","year":"2018","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.berh.2018.08.002_bib75","first-page":"5896906","article-title":"Lack of association between genetic polymorphisms of JAK-STAT signaling pathway genes and acute anterior uveitis in han Chinese","author":"Cheng","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.berh.2018.08.002_bib76","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1152\/physrev.00045.2009","article-title":"Gut microbiota in health and disease","volume":"90","author":"Sekirov","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.berh.2018.08.002_bib77","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.freeradbiomed.2013.11.008","article-title":"Role of the enteric microbiota in intestinal homeostasis and inflammation","volume":"68","author":"Koboziev","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.berh.2018.08.002_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39259","article-title":"Microbiome in inflammatory arthritis and human rheumatic diseases","volume":"68","author":"Scher","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.08.002_bib79","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fmicb.2016.01081","article-title":"The gut microbiota in immune-mediated inflammatory diseases","volume":"7","author":"Forbes","year":"2016","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.berh.2018.08.002_bib80","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.40359","article-title":"Gut microbiota perturbations in reactive arthritis and postinfectious spondyloarthritis","volume":"70","author":"Manasson","year":"2018","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2018.08.002_bib81","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1038\/s41598-018-22125-y","article-title":"Gut microbial composition in patients with psoriasis","volume":"8","author":"Codo\u00f1er","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2018.08.002_bib82","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol"},{"key":"10.1016\/j.berh.2018.08.002_bib83","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/BOR.0000000000000187","article-title":"The intestinal microbiome in spondyloarthritis","volume":"27","author":"Gill","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10384-015-0416-y","article-title":"The microbiome, HLA, and the pathogenesis of uveitis","volume":"60","author":"Rosenbaum","year":"2016","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib85","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/art.38773","article-title":"ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice","volume":"66","author":"Rehaume","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.08.002_bib86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.it.2014.08.003","article-title":"Metabolic control of regulatory T cell development and function","volume":"36","author":"Zeng","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.berh.2018.08.002_bib87","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/acs.jafc.7b05854","article-title":"Food bioactives and their effects on obesity-accelerated inflammatory bowel disease","volume":"66","author":"Chiou","year":"2018","journal-title":"J Agric Food Chem"},{"issue":"1","key":"10.1016\/j.berh.2018.08.002_bib88","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1038\/s41598-017-12163-3","article-title":"Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine","volume":"7","author":"Nakamura","year":"2017","journal-title":"Sci Rep"},{"issue":"1 Supplement","key":"10.1016\/j.berh.2018.08.002_bib89","doi-asserted-by":"crossref","first-page":"218.10","DOI":"10.4049\/jimmunol.198.Supp.218.10","article-title":"Gut microbiota as a source of signals that trigger spontaneous ocular autoimmunity","volume":"198","author":"Salvador","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.berh.2018.08.002_bib90","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1167\/iovs.16-19733","article-title":"Gut microbial alterations associated with protection from autoimmune uveitis","volume":"57","author":"Nakamura","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2018.08.002_bib91","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ajg.2011.72","article-title":"Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis","volume":"106","author":"Khan","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.berh.2018.08.002_bib92","doi-asserted-by":"crossref","first-page":"121192","DOI":"10.3899\/jrheum.121192","article-title":"Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis","volume":"40","author":"Barber","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib93","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2008-1054897","article-title":"[High-dosage combination antibiotic treatment in severe therapy-resistant uveitis and necrotizing (chorio)retinitis]","volume":"183","author":"Fricke","year":"1983","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.berh.2018.08.002_bib94","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/1529-0131(199909)42:9<1894::AID-ANR14>3.0.CO;2-V","article-title":"Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis","volume":"42","author":"Wakefield","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2018.08.002_bib95","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/BOR.0000000000000506","article-title":"Fecal transplants in spondyloarthritis and uveitis: ready for a clinical trial?","volume":"30","author":"Choi","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib96","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation","volume":"9","author":"Bakken","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.berh.2018.08.002_bib97","doi-asserted-by":"crossref","first-page":"e0133925","DOI":"10.1371\/journal.pone.0133925","article-title":"Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis","volume":"10","author":"Damman","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.berh.2018.08.002_bib98","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2036.2012.05220.x","article-title":"Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease","volume":"36","author":"Anderson","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.berh.2018.08.002_bib99","doi-asserted-by":"crossref","first-page":"e019231","DOI":"10.1136\/bmjopen-2017-019231","article-title":"Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial","volume":"8","author":"Kragsnaes","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.berh.2018.08.002_bib100","first-page":"1382","article-title":"Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis","volume":"16","author":"Suzuki","year":"2010","journal-title":"Mol Vis"},{"key":"10.1016\/j.berh.2018.08.002_bib101","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.38291","article-title":"Review: the interleukin-23\/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.08.002_bib102","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.berh.2018.08.002_bib103","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/ar3351","article-title":"IL-17 in spondyloarthritis: is the T-party over?","volume":"13","author":"Yeremenko","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2018.08.002_bib104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.berh.2018.08.002_bib105","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1167\/iovs.07-1390","article-title":"Upregulated IL-23 and IL-17 in beh\u00e7et patients with active uveitis","volume":"49","author":"Chi","year":"2008","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2018.08.002_bib106","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.berh.2018.08.002_bib107","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39732","article-title":"Interleukin-23-Dependent \u03b3\/\u03b4 T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice","volume":"68","author":"Reinhardt","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.08.002_bib108","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00002281-199907000-00004","article-title":"Enthesitis in spondyloarthropathy","volume":"11","author":"McGonagle","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib109","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"\u2018MHC-I-opathy\u2019-unified concept for spondyloarthritis and Beh\u00e7et disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib110","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1167\/iovs.15-17091","article-title":"Revisiting ciliary muscle tendons and their connections with the trabecular meshwork by two photon excitation microscopic imaging","volume":"57","author":"Park","year":"2016","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2018.08.002_bib111","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00318453","article-title":"Type-VI collagen in the human iris and ciliary body","volume":"259","author":"Rittig","year":"1990","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.berh.2018.08.002_bib112","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bjo.2008.154906","article-title":"Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance","volume":"93","author":"Awan","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib113","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00002512-199915060-00004","article-title":"Corticosteroids and glaucoma risk","volume":"15","author":"Tripathi","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.berh.2018.08.002_bib114","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2009.12.003","article-title":"Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids","volume":"117","author":"Thorne","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2018.08.002_bib115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib116","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/10611860701453125","article-title":"Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis","volume":"15","author":"Adibkia","year":"2007","journal-title":"J Drug Target"},{"key":"10.1016\/j.berh.2018.08.002_bib117","first-page":"1277","article-title":"Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period","volume":"30","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib118","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/eye.2008.198","article-title":"Methotrexate: an option for preventing the recurrence of acute anterior uveitis","volume":"23","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.berh.2018.08.002_bib119","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/art.21197","article-title":"Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti\u2013tumor necrosis factor agents infliximab and etanercept","volume":"52","author":"Braun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.08.002_bib120","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.092585","article-title":"Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib121","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/annrheumdis-2016-210931","article-title":"Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register","volume":"76","author":"Lie","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib122","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1185\/03007995.2014.969368","article-title":"Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database","volume":"30","author":"Wendling","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.berh.2018.08.002_bib123","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/acr.22848","article-title":"Observed incidence of uveitis following certolizumab pegol treatment in patients with axial spondyloarthritis","volume":"68","author":"Rudwaleit","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2018.08.002_bib124","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10792-016-0239-y","article-title":"Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis","volume":"37","author":"Yazgan","year":"2017","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.berh.2018.08.002_bib125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semarthrit.2016.03.002","article-title":"Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients","volume":"46","author":"Calvo-R\u00edo","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.08.002_bib126","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/BOR.0000000000000301","article-title":"Targeting the interleukin-23\/17 axis in axial spondyloarthritis","volume":"28","author":"Paine","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib127","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17a inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2018.08.002_bib128","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ophtha.2012.09.040","article-title":"Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials","volume":"120","author":"Dick","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2018.08.002_bib129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3899\/jrheum.170429","article-title":"Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: 52-week results from a phase III study (SPIRIT-P1)","volume":"45","author":"van der Heijde","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2018.08.002_bib130","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa1503824","article-title":"Phase 3 studies comparing brodalumab with ustekinumab in psoriasis","volume":"373","author":"Lebwohl","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2018.08.002_bib131","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.berh.2018.08.002_bib132","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.20965","article-title":"Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine","volume":"52","author":"Ikeuchi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.08.002_bib133","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.4049\/jimmunol.1202677","article-title":"Role of IL-22- and TNF-\u03b1-producing Th22 cells in uveitis patients with Behcet's disease","volume":"190","author":"Sugita","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.berh.2018.08.002_bib134","article-title":"Increased expression of IL-22 is associated with disease activity in Behcet's disease","volume":"8","author":"Cai","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.berh.2018.08.002_bib135","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.4049\/jimmunol.181.7.5147","article-title":"Gene expression profiling in autoimmune noninfectious uveitis disease","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.berh.2018.08.002_bib136","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","article-title":"Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.08.002_bib137","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2217\/imt-2017-0118","article-title":"Tofacitinib in the treatment of active rheumatoid arthritis in adults","volume":"10","author":"Fleischmann","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.berh.2018.08.002_bib138","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/annrheumdis-2013-205056","article-title":"Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor","volume":"73","author":"Kavanaugh","year":"2014","journal-title":"Ann Rheum Dis"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694218300391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694218300391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T07:23:04Z","timestamp":1693984984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694218300391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1521694218300391"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2018.08.002","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uveitis in the Spondyloarthopathies","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}